Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 May 2018 Photo Facebook
Kovsies aim top 6 in Varsity hockey Cheslyn Neethling
Cheslyn Neethling will lead the Kovsie men’s hockey team in the Varsity Hockey tournament.

The Kovsie men’s hockey team hope to draw inspiration from their victory over the North-West University recently when they face their old rivals in the opening round of the Varsity Hockey tournament.

The tournament for men, which is contested biannually, starts on Friday 4 May 2018.

The Kovsies played the Pukke in two matches in Potchefstroom at the end of March with both sides on the winning side once each.

According to the coach Braam van Wyk it will give them a lot of confidence when they come up against the Pukke on Friday afternoon (4 May) in Johannesburg.

“We hope to finish in the top six, anything better than that will be a bonus,” said Van Wyk, in his third year as coach of the team.

They reached the semi-final in 2014 and ended seventh in 2016.

It is a short tournament of just two-and-a-half weeks with the final on 21 May 2018. 

On Saturday 5 May they tackle the University of Johannesburg who won the inaugural men’s tournament in 2014 and defended it in 2016.

The Madibaz lay in wait on Sunday 6 May and on Monday 7 Mayat the University of Cape Town. 

Van Wyk, who played for the Kovsies between 2006 and 2009, said he is in favour of the power play. Each side has one in a match. For three minutes the team will be without two players, with goals worth two points. In addition, all field goals are worth two points. If a match is drawn it will go straight to a shootout.

The Kovsies are led by Cheslyn Neethling. Two players, Egon van der Merwe and Jan Willem Ras, will feature in their third Varsity tournament.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept